Privacy-preserving techniques for decentralized and secure machine learning in drug discovery
Abstract
Data availability, data security, and privacy concerns often hamper optimal performance efficiency of machine learning (ML) techniques. Therefore, novel techniques for the utilization of private/sensitive data in the field of drug discovery have been proposed for ML model-building tasks. Some examples of the different techniques are secure multiparty computation, distributed deep learning, homomorphic encryption, blockchain-based peer-to-peer networking, differential privacy, and federated learning, as well as combinations of such techniques. In this paper, we present an overview of these techniques for decentralized ML to illustrate its benefits and drawbacks in the field of drug discovery.
How strong is the evidence?
Evidence Hub reads this as a review, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Active Learning during Federated Learning for Object Detection
- Fairness-aware federated learning
- Decentralized Federated Learning
- Building a Personally Identifiable Information Recognizer in a Privacy Preserved Manner Using Automated Annotation and Federated Learning
- Preservation of Patient Level Privacy: Federated Classification and Calibration Models
- Efficient explainable federated learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.